Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China · Delayed Price · Currency is CNY 13.62
-0.08 (-0.58%)
May 19, 2026, 10:35 AM CST
SHA:603108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -502.45 | -518.15 | 55.28 | 273.3 | 417.75 | 380.23 |
Depreciation & Amortization | 361.47 | 361.47 | 373.05 | 375.02 | 384.18 | 365.2 |
Other Amortization | 28.16 | 28.16 | 49.01 | 26.31 | 30.84 | 25.11 |
Loss (Gain) From Sale of Assets | -3.12 | -3.12 | -11.46 | -11.77 | -6.18 | -1.73 |
Asset Writedown & Restructuring Costs | 212.31 | 212.31 | 34.11 | 24.53 | 38.22 | 3.08 |
Loss (Gain) From Sale of Investments | -20.79 | -20.79 | -109.82 | -232 | -137.05 | -130.72 |
Provision & Write-off of Bad Debts | - | - | 81.71 | 88.9 | 198.37 | 51.91 |
Other Operating Activities | 390.13 | 476.31 | 459.28 | 518.77 | 571.48 | 507.49 |
Change in Accounts Receivable | -70.25 | -70.25 | -115.07 | 357.35 | -2,350 | -668.83 |
Change in Inventory | -521.07 | -521.07 | -72.59 | 93.37 | -157.62 | -360.17 |
Change in Accounts Payable | 748.94 | 748.94 | -66.98 | -781.88 | 665.31 | 206.87 |
Operating Cash Flow | 566.73 | 637.22 | 646.95 | 729.72 | -428.86 | 371.11 |
Operating Cash Flow Growth | -29.55% | -1.50% | -11.34% | - | - | 14.74% |
Capital Expenditures | -268.83 | -250.48 | -229.16 | -319.88 | -272.12 | -301.09 |
Sale of Property, Plant & Equipment | 16.01 | 17.82 | 7.96 | 22.86 | 20.84 | 16.44 |
Cash Acquisitions | - | - | -0.18 | -122.28 | -18.93 | -154.45 |
Divestitures | - | - | - | 99.25 | - | - |
Investment in Securities | -37.73 | -62.74 | -198.08 | -5.13 | -94.01 | -1.38 |
Other Investing Activities | -58.26 | 55.94 | -39.72 | 71.6 | 37.32 | 24.9 |
Investing Cash Flow | -348.81 | -239.46 | -460.67 | -227.34 | -322.57 | -415.08 |
Short-Term Debt Issued | - | - | 12 | 5 | - | - |
Long-Term Debt Issued | - | 7,580 | 9,470 | 10,013 | 8,443 | 6,447 |
Total Debt Issued | 8,133 | 7,580 | 9,482 | 10,018 | 8,443 | 6,447 |
Long-Term Debt Repaid | - | -7,686 | -8,822 | -9,835 | -7,393 | -5,512 |
Net Debt Issued (Repaid) | 87.06 | -106.21 | 659.83 | 182.85 | 1,051 | 935.6 |
Issuance of Common Stock | - | - | 28 | - | - | - |
Common Dividends Paid | -274.78 | -281.35 | -337.34 | -377.52 | -244.17 | -272.79 |
Other Financing Activities | -222.39 | -231.84 | -258.19 | -136.64 | -318.35 | -567.86 |
Financing Cash Flow | -410.11 | -619.4 | 92.3 | -331.32 | 488.13 | 94.95 |
Foreign Exchange Rate Adjustments | -0.69 | -0.32 | -2.86 | -0.07 | 0.47 | -1.36 |
Net Cash Flow | -192.88 | -221.97 | 275.72 | 171 | -262.83 | 49.63 |
Free Cash Flow | 297.9 | 386.74 | 417.78 | 409.84 | -700.98 | 70.03 |
Free Cash Flow Growth | -48.90% | -7.43% | 1.94% | - | - | - |
Free Cash Flow Margin | 4.35% | 5.53% | 5.03% | 4.48% | -6.68% | 0.79% |
Free Cash Flow Per Share | 0.50 | 0.64 | 0.68 | 0.70 | -1.18 | 0.12 |
Cash Interest Paid | - | - | - | - | 9.42 | 6.27 |
Cash Income Tax Paid | 317.43 | 350.63 | 548.57 | 546.76 | 509.43 | 488.64 |
Levered Free Cash Flow | 708.86 | 830.02 | 252.85 | 219.42 | -1,062 | -567.62 |
Unlevered Free Cash Flow | 708.86 | 830.02 | 448.38 | 428.19 | -863.38 | -391.42 |
Change in Working Capital | 101.03 | 101.03 | -284.21 | -333.33 | -1,906 | -843.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.